Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04285684 · ClinicalTrials.gov registry record · Early Phase 1
The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women
A Early Phase 1 study, sponsored by The Ketamine Research Foundation.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 4
- Enrollment target
NCT04285684 is a Early Phase 1 study that has completed, run by The Ketamine Research Foundation. The registered enrollment target is 4 participants.
The verdict
NCT04285684, a Early Phase 1 study, has completed, sponsored by The Ketamine Research Foundation.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
Quantification of Ketamine in Breast Milk at 3 hour Intervals up to 30 hours-- obtained from lactating women who receive 2 different Intramuscular injections of ketamine on two separate days at least 5 days apart.
Interventions
- DRUG ketamine in lactation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2019-12-20 |
| Est. Completion | 2021-01-05 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04285684
The ClinicalTrials.gov registry entry for NCT04285684 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Ketamine Research Foundation, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ketamine in lactation is the first listed.
NCT04285684 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04285684 about?
NCT04285684 is a clinical study titled "The Pharmacokinetics of Ketamine in the Breast Milk of Lactating Women". Quantification of Ketamine in Breast Milk at 3 hour Intervals up to 30 hours-- obtained from lactating women who receive 2 different Intramuscular injections of ketamine on two separate days at least 5 days apart.
What is the current status of trial NCT04285684?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 4 participants. The study started on 2019-12-20. Estimated completion is 2021-01-05.
What interventions are being tested in trial NCT04285684?
The interventions under investigation include: ketamine in lactation (DRUG).
Who is sponsoring clinical trial NCT04285684?
This trial is sponsored by The Ketamine Research Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.